IMHO, this is a near impossible task. The BOD already owned most part of the company and as I said many months ago. The value propositions of the BOD has misaligned with the loyal shareholders, they could easily accept a lowball 20mil or 50mil offer and walk off.
Mark from pharmaceutical arm may just get a high profile position in the new company and $1m per annual annum salary if takeover ever happens. Everyone wins within the team and the one who paid loyalty tax lost.
IHL Price at posting:
4.1¢ Sentiment: Sell Disclosure: Not Held